Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Desulfovibrionaceae - : bifidobacterium |
📓
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , Html Article Publication |
| Decreases Desulfovibrionaceae - : bifidobacterium |
👪
The effect of synbiotics Bifidobacterium infantis and milk oligosaccharides on shaping gut microbiota community structure and NASH treatment. Data in brief (Data Brief ) Vol: 19 Issue Pages: 1025-1029 Pub: 2018 Aug Epub: 2018 May 24 Authors Jena PK , Sheng L , Nagar N , Wu C , Barile D , Mills DA , Wan YY , Html Article Publication |
| Decreases Desulfovibrionaceae - : bifidobacterium |
📓
Curated database of commensal, symbiotic and pathogenic microbiota Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , Publication |
| Decreases Desulfovibrionaceae - : bifidobacterium |
👪
Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. Journal of food biochemistry (J Food Biochem ) Vol: 44 Issue 11 Pages: e13489 Pub: 2020 Nov Epub: 2020 Sep 29 Authors Jing W , Liu Q , Wang W , Publication |
| 0 π | π’ 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]